BlackRock’s Safeguard Scientifics, Inc. SFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-380,228
| Closed | -$298K | – | 5480 |
|
|
2023
Q4 | $298K | Hold |
380,228
| – | – | ﹤0.01% | 4543 |
|
|
2023
Q3 | $380K | Sell |
380,228
-36,433
| -9% | -$47.4K | ﹤0.01% | 4494 |
|
|
2023
Q2 | $687K | Sell |
416,661
-11,003
| -3% | -$19.2K | ﹤0.01% | 4394 |
|
|
2023
Q1 | $736K | Buy |
427,664
+1,037
| +0.2% | +$2.86K | ﹤0.01% | 4435 |
|
|
2022
Q4 | $1.32M | Buy |
426,627
+822
| +0.2% | +$2.76K | ﹤0.01% | 4314 |
|
|
2022
Q3 | $1.59M | Sell |
425,805
-1,272
| -0.3% | -$5.11K | ﹤0.01% | 4299 |
|
|
2022
Q2 | $1.59M | Sell |
427,077
-5,701
| -1% | -$23.8K | ﹤0.01% | 4349 |
|
|
2022
Q1 | $2.26M | Sell |
432,778
-152,023
| -26% | -$920K | ﹤0.01% | 4334 |
|
|
2021
Q4 | $4.3M | Buy |
584,801
+3,173
| +0.5% | +$24.8K | ﹤0.01% | 4057 |
|
|
2021
Q3 | $5.17M | Buy |
581,628
+2,756
| +0.5% | +$22.1K | ﹤0.01% | 3944 |
|
|
2021
Q2 | $4.49M | Sell |
578,872
-1,202,782
| -68% | -$8.2M | ﹤0.01% | 3921 |
|
|
2021
Q1 | $12.2M | Buy |
1,781,654
+51,410
| +3% | +$373K | ﹤0.01% | 3463 |
|
|
2020
Q4 | $11M | Buy |
1,730,244
+36,790
| +2% | +$230K | ﹤0.01% | 3305 |
|
|
2020
Q3 | $9.28M | Buy |
1,693,454
+4,498
| +0.3% | +$26.9K | ﹤0.01% | 3259 |
|
|
2020
Q2 | $11.8M | Buy |
1,688,956
+131,034
| +8% | +$829K | ﹤0.01% | 3093 |
|
|
2020
Q1 | $8.64M | Sell |
1,557,922
-27,695
| -2% | -$247K | ﹤0.01% | 3077 |
|
|
2019
Q4 | $17.4M | Buy |
1,585,617
+73,975
| +5% | +$845K | ﹤0.01% | 2957 |
|
|
2019
Q3 | $17.1M | Buy |
1,511,642
+282,977
| +23% | +$3.37M | ﹤0.01% | 2905 |
|
|
2019
Q2 | $14.8M | Sell |
1,228,665
-1,749
| -0.1% | -$20.5K | ﹤0.01% | 3015 |
|
|
2019
Q1 | $13.3M | Sell |
1,230,414
-4,814
| -0.4% | -$48.8K | ﹤0.01% | 2965 |
|
|
2018
Q4 | $10.6M | Sell |
1,235,228
-697
| -0.1% | -$6.08K | ﹤0.01% | 3052 |
|
|
2018
Q3 | $11.6M | Sell |
1,235,925
-2,424
| -0.2% | -$26.3K | ﹤0.01% | 3166 |
|
|
2018
Q2 | $15.9M | Sell |
1,238,349
-263,398
| -18% | -$3.4M | ﹤0.01% | 2987 |
|
|
2018
Q1 | $18.4M | Sell |
1,501,747
-73,338
| -5% | -$892K | ﹤0.01% | 2820 |
|
|
2017
Q4 | $17.6M | Sell |
1,575,085
-31,417
| -2% | -$402K | ﹤0.01% | 2847 |
|
|
2017
Q3 | $21.4M | Buy |
1,606,502
+12,085
| +0.8% | +$149K | ﹤0.01% | 2768 |
|
|
2017
Q2 | $19M | Sell |
1,594,417
-54,399
| -3% | -$641K | ﹤0.01% | 2815 |
|
|
2017
Q1 | $20.9M | Buy |
1,648,816
+1,642,978
| +28,143% | +$20.7M | ﹤0.01% | 2730 |
|
|
2016
Q4 | $78K | Hold |
5,838
| – | – | ﹤0.01% | 2704 |
|
|
2016
Q3 | $76K | Hold |
5,838
| – | – | ﹤0.01% | 2755 |
|
|
2016
Q2 | $73K | Buy |
5,838
+4,322
| +285% | +$58K | ﹤0.01% | 2742 |
|
|
2016
Q1 | $20K | Buy |
1,516
+888
| +141% | +$11.2K | ﹤0.01% | 2862 |
|
|
2015
Q4 | $9K | Hold |
628
| – | – | ﹤0.01% | 2940 |
|
|
2015
Q3 | $10K | Hold |
628
| – | – | ﹤0.01% | 2738 |
|
|
2015
Q2 | $12K | Hold |
628
| – | – | ﹤0.01% | 2694 |
|
|
2015
Q1 | $11K | Hold |
628
| – | – | ﹤0.01% | 2697 |
|
|
2014
Q4 | $12K | Hold |
628
| – | – | ﹤0.01% | 2670 |
|
|
2014
Q3 | $12K | Hold |
628
| – | – | ﹤0.01% | 2620 |
|
|
2014
Q2 | $13K | Sell |
628
-28
| -4% | -$563 | ﹤0.01% | 2622 |
|
|
2014
Q1 | $15K | Hold |
656
| – | – | ﹤0.01% | 2512 |
|
|
2013
Q4 | $13K | Hold |
656
| – | – | ﹤0.01% | 2576 |
|
|
2013
Q3 | $10K | Hold |
656
| – | – | ﹤0.01% | 2662 |
|
|
2013
Q2 | $11K | Buy |
+656
| New | +$10.4K | ﹤0.01% | 2600 |
|
Other funds holding SFE
CP
RA
FWM
HNB
BlackRock's SFE Position: Q1 2024 in Review
BlackRock sold out of Safeguard Scientifics, Inc. (SFE) in Q1 2024, closing a stake of 380,228 shares — an estimated $298K sold.
BlackRock first reported a position in SFE in Q2 2013 and held it in 43 quarters. The position peaked at $21.4M in Q3 2017. 4 funds tracked by Wall St. Rank hold SFE as of Q1 2024.
- BlackRock reported no remaining Safeguard Scientifics, Inc. position as of Q1 2024 after selling out during the quarter.
- BlackRock sold 380,228 Safeguard Scientifics, Inc. shares in Q1 2024, an estimated $298K.
- BlackRock first reported a position in Safeguard Scientifics, Inc. in Q2 2013 and held it in 43 quarters.
- BlackRock's Safeguard Scientifics, Inc. position peaked at $21.4M in Q3 2017.
- 4 funds tracked by Wall St. Rank held Safeguard Scientifics, Inc. as of Q1 2024.
Based on BlackRock's 13F filing for Q1 2024, filed 10 May 2024.